The contract involves the renewal of DBP licenses for ZEMAX, a software used for optical design. This renewal is being managed by the Food and Drug Administration (FDA) and falls under the NAICS code 511210, which pertains to software publishers. The contract is currently in the forecast stage as of March 11, 2026, indicating that it is planned but not yet finalized. Specific details about the place of performance, set-aside status, and the contracting officer are not provided at this time. Points of contact include the CDRH Acquisition Liaison, reachable via a designated FDA email, and a contracting officer who has yet to be determined. The opportunity is listed on the FDA’s industry forecast platform, which serves to inform potential vendors about upcoming contract opportunities. This renewal is critical for maintaining software licenses essential for the FDA’s optical design and analysis capabilities.
Renewal of ZEMAX DBP software licenses by FDA under NAICS 511210, forecasted March 2026.
Agency
Food and Drug Administration → Food And Drug Administration
View AgencyNAICS
511210 - NAICS Code 511210
View NAICSPlace of Performance
US
Set-Aside
No contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
N/A
2 contacts available
Start a free trial to view contact information.